Candriam SCA’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Candriam SCA’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-210,000	Closed	-$2.61M	–	720
2016 Q4	$2.61M	Buy	210,000 +60,000	+40%	+$723K	0.06%	315
2016 Q3	$2.05M	Sell	150,000 -110,000	-42%	-$1.1M	0.05%	347
2016 Q2	$1.92M	Buy	260,000 +90,000	+53%	+$675K	0.05%	319
2016 Q1	$1.08M	Buy	+170,000	New	+$953K	0.03%	416

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Candriam SCA's ARIA Position: Q1 2017 in Review

Candriam SCA sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 210,000 shares — an estimated $2.61M sold.

Candriam SCA first reported a position in ARIA in Q1 2016 and held it in 4 quarters. The position peaked at $2.61M in Q4 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Candriam SCA reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Candriam SCA sold 210,000 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $2.61M.
Candriam SCA first reported a position in Ariad Pharmaceuticals Inc in Q1 2016 and held it in 4 quarters.
Candriam SCA's Ariad Pharmaceuticals Inc position peaked at $2.61M in Q4 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Candriam SCA's 13F filing for Q1 2017, filed 21 Apr 2017.